Chimeric antigen receptor therapy in hematological malignancies: antigenic targets and their clinical research progress-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Chimeric antigen receptor therapy in hematological malignancies: antigenic targets and their clinical research progress

Published:2020-05-09 Issue:8 Volume:99 Page:1681-1699
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Zhao Juanjuan,Wu Meirong,Li Zhifeng,Su Sheng,Wen Yin,Zhang Litian,Li Yuhua

Funder

Science and Technology Program of Guangzhou

Natural Science Foundation of Guangdong Province

Frontier Research Program of Guangzhou Regenerative Medicine and Health Guangdong Laboratory

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00277-020-04020-7.pdf

Reference186 articles.

1. Huang Q, Xia J, Wang L et al (2018) miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy. J Hematol Oncol 11:90. https://doi.org/10.1186/s13045-018-0600-x

2. Riccione K, Suryadevara CM, Snyder D, Cui X, Sampson JH, Sanchez-Perez L (2015) Generation of CAR T cells for adoptive therapy in the context of glioblastoma standard of care. J Vis Exp 96:e52397. https://doi.org/10.3791/52397

3. Kochenderfer JN, Dudley ME, Feldman SA et al (2012) B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells. Blood 118(12):2709–2720. https://doi.org/10.1182/blood-2011-10-384388

4. Porter DL, Levine BL, Kalos M, Bagg A, June CH (2011) Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia. N Engl J Med 365(8):725–733. https://doi.org/10.1056/NEJMoa1103849

5. Knochelmann HM, Smith AS, Dwyer CJ, Wyatt MM, Mehrotra S, Paulos CM (2018) CAR T cells in solid tumors: blueprints for building effective therapies. Front Immunol 9:1740. https://doi.org/10.3389/fimmu.2018.01740

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Artificial intelligence assisted diagnosis of chronic lymphocytic leukemia in a historic pediatric case using large language models;Annals of Hematology;2024-07-29

2. Advances in CAR-NK cell therapy for hematological malignancies;Frontiers in Immunology;2024-06-28

3. CAR-NK cells in combination therapy against cancer: A potential paradigm;Heliyon;2024-03

4. NK-92MI Cells Engineered with Anti-claudin-6 Chimeric Antigen Receptors in Immunotherapy for Ovarian Cancer;International Journal of Biological Sciences;2024

5. CAR T-Cell Therapy in the Older Person: Indications and Risks;Current Oncology Reports;2022-04-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3